Advertisement

Drug Allergy and Adverse Drug Reactions

  • Faoud T. Ishmael
  • Ronaldo Paolo Panganiban
  • Simin Zhang
Living reference work entry

Abstract

Adverse reactions to drugs are common and may result in increased healthcare utilization and cost. It is important to distinguish between medication side effects and hypersensitivity, as recommendations regarding medication use and diagnostic testing depend on this classification. Hypersensitivity is driven by immune reactions to medications and can be categorized according to the Gell and Coombs classification, as discussed in this chapter. Hypersensitivity to antibiotics account for a majority of allergic drug reactions. However, reactions can occur to almost any drug, and allergy to anesthetics, chemotherapeutic agents, NSAIDs, biologics, and radiocontrast are important considerations. This chapter will review the mechanisms and clinical features that underlie allergy to each of these classes of medications. Furthermore, approaches to diagnosis and management of drug hypersensitivity will be discussed. The chapter will also review severe drug reactions, such as Stevens-Johnson Syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, and drug rash with eosinophils and systemic symptoms, as these are life threatening reactions that require immediate recognition.

Keywords

Drug allergy Hypersensitivity Desensitization Mechanism 

References

  1. Atanasković-Marković M, Gaeta F, Medjo B, Viola M, Nestorović B, Romano A. Tolerability of Meropenem in children with IgE-mediated hypersensitivity to penicillins. Allergy. 2008;63:237–40.CrossRefPubMedGoogle Scholar
  2. Bachot N, Revuz J, Roujeau J-C. Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal Necrolysis: a prospective noncomparative study showing no benefit on mortality or progression. Arch Dermatol. 2003;139:33–6.CrossRefPubMedGoogle Scholar
  3. Ballow M. Safety of Igiv therapy and infusion-related adverse events. Immunol Res. 2007;38:122–32.CrossRefPubMedGoogle Scholar
  4. Banerji A, Clark S, Blanda M, Lovecchio F, Snyder B, Camargo CA. Multicenter study of patients with angiotensin-converting enzyme inhibitor-induced angioedema who present to the emergency department. Ann Allergy Asthma Immunol. 2008;100:327–32.CrossRefPubMedGoogle Scholar
  5. Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC. Clinical classification of cases of toxic epidermal Necrolysis, Stevens-Johnson syndrome, and erythema Multiforme. Arch Dermatol. 1993a;129:92–6.CrossRefPubMedGoogle Scholar
  6. Bastuji-Garin S, Zahedi M, Guillaume JC, Roujeau JC. Toxic epidermal Necrolysis (Lyell syndrome) in 77 elderly patients. Age Ageing. 1993b;22:450–6.CrossRefPubMedGoogle Scholar
  7. Berkun Y, Ben-Zvi A, Levy Y, Galili D, Shalit M. Evaluation of adverse reactions to local anesthetics: experience with 236 patients. Ann Allergy Asthma Immunol. 2003;91:342–5.CrossRefPubMedGoogle Scholar
  8. Blaxall BC, Pellett AC, Wu SC, Pende A, Port JD. Purification and characterization of Beta-adrenergic receptor Mrna-binding proteins. J Biol Chem. 2000;275:4290–7.CrossRefPubMedGoogle Scholar
  9. Campi P, Benucci M, Manfredi M, Demoly P. Hypersensitivity reactions to biological agents with special emphasis on tumor necrosis factor-alpha antagonists. Curr Opin Allergy Clin Immunol. 2007;7:393–403.CrossRefPubMedGoogle Scholar
  10. Castells MC, Tennant NM, Sloane DE, Hsu FI, Barrett NA, Hong DI, Laidlaw TM, Legere HJ, Nallamshetty SN, Palis RI, Rao JJ, Berlin ST, Campos SM, Matulonis UA. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases. J Allergy Clin Immunol. 2008;122:574–80.CrossRefPubMedGoogle Scholar
  11. Chandra RK, Joglekar SA, Tomas E. Penicillin allergy: anti-penicillin IgE antibodies and immediate hypersensitivity skin reactions employing major and minor determinants of penicillin. Arch Dis Child. 1980;55:857–60.CrossRefPubMedPubMedCentralGoogle Scholar
  12. Cheifetz A, Smedley M, Martin S, Reiter M, Leone G, Mayer L, Plevy S. The incidence and management of infusion reactions to infliximab: a large center experience. Am J Gastroenterol. 2003;98:1315–24.CrossRefPubMedGoogle Scholar
  13. Chung CH, Mirakhur B, Chan E, Le Q-T, Berlin J, Morse M, Murphy BA, Satinover SM, Hosen J, Mauro D, Slebos RJ, Zhou Q, Gold D, Hatley T, Hicklin DJ, Platts-Mills TAE. Cetuximab-induced anaphylaxis and IgE specific for galactose-Α-1,3-galactose. N Engl J Med. 2008;358:1109–17.CrossRefPubMedPubMedCentralGoogle Scholar
  14. Contributors, W. 2010. Drug allergy: an updated practice parameter.Google Scholar
  15. Coombs R, Gell P. The classification of allergic reactions underlying disease. Clin Asp Immunol. 1963;319:575–596Google Scholar
  16. Davis CM, Shearer WT. Diagnosis and management of HIV drug hypersensitivity. J Allergy Clin Immunol. 2008;121:826–832.E5.CrossRefPubMedGoogle Scholar
  17. Depestel DD, Benninger MS, Danziger L, Laplante KL, May C, Luskin A, Michael P, Hadley JA. Cephalosporin use in treatment of patients with penicillin allergies. J Am Pharm Assoc. 2008;48:530–40.CrossRefGoogle Scholar
  18. Dibbern DA, Montanaro A. Allergies to sulfonamide antibiotics and sulfur-containing drugs. Ann Allergy Asthma Immunol. 2008;100:91–100; quiz 100–103, 111CrossRefPubMedGoogle Scholar
  19. Eisenhauer EA, Ten Bokkel Huinink WW, Swenerton KD, Gianni L, Myles J, Van Der Burg ME, Kerr I, Vermorken JB, Buser K, Colombo N. European-Canadian randomized trial of paclitaxel in relapsed ovarian Cancer: high-dose versus low-dose and long versus short infusion. J Clin Oncol Off J Am Soc Clin Oncol. 1994;12:2654–66.CrossRefGoogle Scholar
  20. Gadde J, Spence M, Wheeler B, Adkinson NF. Clinical experience with penicillin skin testing in a large Inner-City Std clinic. JAMA. 1993;270:2456–63.CrossRefPubMedGoogle Scholar
  21. González-López MA, Martínez-Taboada VM, González-Vela MC, Blanco R, Fernández-Llaca H, Rodríguez-Valverde V, Val-Bernal JF. Recall injection-site reactions associated with Etanercept therapy: report of two new cases with Immunohistochemical analysis. Clin Exp Dermatol. 2007;32:672–4.CrossRefPubMedGoogle Scholar
  22. Gonzalo A, Rose ME, Ramirez-Atamoros MT, Hammel J, Gordon SM, Arroliga AC, Arroliga ME. Penicillin skin testing in patients with a history of Β-lactam allergy. Ann Allergy Asthma Immunol. 2007;98:355–9.CrossRefGoogle Scholar
  23. Hetherington S, Mcguirk S, Powell G, Cutrell A, Naderer O, Spreen B, Lafon S, Pearce G, Steel H. Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor Abacavir. Clin Ther. 2001;23:1603–14.CrossRefPubMedGoogle Scholar
  24. Idsoe O, Guthe T, Willcox R, De Weck A. Nature and extent of penicillin side-reactions, with particular reference to fatalities from anaphylactic shock. Bull World Health Organ. 1968;38:159.PubMedPubMedCentralGoogle Scholar
  25. Joint Task Force on Practice Parameters, American Academy of Allergy, Asthma and Immunology, American College of Allergy, Asthma and Immunology, Joint Council of Allergy, Asthma and Immunology. Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol. 2010;105:259–73.CrossRefGoogle Scholar
  26. Khan DA, Solensky R. Drug allergy. J Allergy Clin Immunol. 2010;125:S126–S137. E1.CrossRefPubMedGoogle Scholar
  27. Kvisselgaard AD, Kroigaard M, Mosbech HF, Garvey LH. No cases of perioperative allergy to local Anaesthetics in the Danish Anaesthesia allergy Centre. Acta Anaesthesiol Scand. 2017;61:149–55.CrossRefPubMedGoogle Scholar
  28. Macy E. The clinical evaluation of penicillin allergy: what is necessary, sufficient and safe given the materials currently available? Clin Exp Allergy. 2011;41:1498–501.CrossRefPubMedGoogle Scholar
  29. Macy E. Penicillin and Beta-lactam allergy: epidemiology and diagnosis. Curr Allergy Asthma Rep. 2014;14:476.CrossRefPubMedGoogle Scholar
  30. Macy E, Bernstein JA, Castells MC, Gawchik SM, Lee TH, Settipane RA, Simon RA, Wald J, Woessner KM. Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper. Ann Allergy Asthma Immunol. 2007;98:172–4.CrossRefPubMedGoogle Scholar
  31. Macy E, Contreras R. Health care use and serious infection prevalence associated with penicillin "allergy" in hospitalized patients: a cohort study. J Allergy Clin Immunol. 2014;133:790–6.CrossRefPubMedGoogle Scholar
  32. Mckenna JK, Leiferman KM. Dermatologic drug reactions. Immunol Allergy Clin N Am. 2004;24:399–423.CrossRefGoogle Scholar
  33. Morales-Cabeza C, Roa-Medellin D, Torrado I, De Barrio M, Fernandez-Alvarez C, Montes-Acenero JF, De La Riva I, Prieto-Garcia A. Immediate reactions to iodinated contrast media. Ann Allergy Asthma Immunol. 2017;119:553.CrossRefPubMedGoogle Scholar
  34. Nussberger J, Cugno M, Cicardi M. Bradykinin-mediated angioedema. N Engl J Med. 2002;347:621–2.CrossRefPubMedGoogle Scholar
  35. Parker CW, Deweck A, Kern M, Eisen H. The preparation and some properties of Penicillenic acid derivatives relevant to penicillin hypersensitivity. J Exp Med. 1962;115:803–19.CrossRefPubMedGoogle Scholar
  36. Peyrière H, Dereure O, Breton H, Demoly P, Cociglio M, Blayac JP, Hillaire-Buys D, Network of the French Pharmacovigilance Centers. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a Dress syndrome really exist? Br J Dermatol. 2006;155:422–8.CrossRefPubMedGoogle Scholar
  37. Pichler WJ. Delayed drug hypersensitivity reactions. Ann Intern Med. 2003;139:683–93.CrossRefPubMedGoogle Scholar
  38. Romano A, Viola M, Guéant-Rodriguez R-M, Gaeta F, Valluzzi R, Guéant J-L. Brief communication: tolerability of Meropenem in patients with IgE-mediated hypersensitivity to penicillins meropenem in penicillin-allergic patients. Ann Intern Med. 2007;146:266–9.CrossRefPubMedGoogle Scholar
  39. Roujeau J-C, Kelly JP, Naldi L, Rzany B, Stern RS, Anderson T, Auquier A, Bastuji-Garin S, Correia O, Locati F, Mockenhaupt M, Paoletti C, Shapiro S, Shear N, Schöpf E, Kaufman DW. Medication use and the risk of Stevens–Johnson syndrome or toxic epidermal Necrolysis. N Engl J Med. 1995;333:1600–8.CrossRefPubMedGoogle Scholar
  40. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med. 1994;331:1272–85.CrossRefPubMedGoogle Scholar
  41. Schaerli P, Britschgi M, Keller M, Steiner UC, Steinmann LS, Moser B, Pichler WJ. Characterization of human T cells that regulate Neutrophilic skin inflammation. J Immunol (Baltimore, Md.: 1950). 2004;173:2151–8.CrossRefGoogle Scholar
  42. Schmid DA, Depta JPH, Lüthi M, Pichler WJ. Transfection of drug-specific T-cell receptors into hybridoma cells: tools to monitor drug interaction with T-cell receptors and evaluate cross-reactivity to related compounds. Mol Pharmacol. 2006;70:356–65.PubMedGoogle Scholar
  43. Sese L, Gaouar H, Autegarden JE, Alari A, Amsler E, Vial-Dupuy A, Pecquet C, Frances C, Soria A. Immediate hypersensitivity to iodinated contrast media: diagnostic accuracy of skin tests and intravenous provocation test with low dose. Clin Exp Allergy. 2016;46:472–8.CrossRefPubMedGoogle Scholar
  44. Shiohara T, Iijima M, Ikezawa Z, Hashimoto K. The diagnosis of a Dress syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br J Dermatol. 2007;156:1083–4.CrossRefPubMedGoogle Scholar
  45. Sogn DD, Evans R, Shepherd GM, Casale TB, Condemi J, Greenberger PA, Kohler PF, Saxon A, Summers RJ, Vanarsdel PP. Results of the National Institute of Allergy and Infectious Diseases collaborative clinical trial to test the predictive value of skin testing with major and minor penicillin derivatives in hospitalized adults. Arch Intern Med. 1992;152:1025–32.CrossRefPubMedGoogle Scholar
  46. Speeckaert MM, Speeckaert R, Lambert J, Brochez L. Acute generalized Exanthematous Pustulosis: an overview of the clinical, immunological and diagnostic concepts. Eur J Dermatol. 2010;20:425–33.PubMedGoogle Scholar
  47. Stevenson DD. Aspirin sensitivity and desensitization for asthma and sinusitis. Curr Allergy Asthma Rep. 2009;9:155–63.CrossRefPubMedGoogle Scholar
  48. Stevenson DD, Szczeklik A. Clinical and pathologic perspectives on aspirin sensitivity and asthma. J Allergy Clin Immunol. 2006;118:773–86. Quiz 787–788CrossRefPubMedGoogle Scholar
  49. Strom BL, Schinnar R, Apter AJ, Margolis DJ, Lautenbach E, Hennessy S, Bilker WB, Pettitt D. Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics. N Engl J Med. 2003;349:1628–35.CrossRefPubMedGoogle Scholar
  50. Trcka J, Schmidt C, Seitz CS, Brocker EB, Gross GE, Trautmann A. Anaphylaxis to iodinated contrast material: nonallergic hypersensitivity or IgE-mediated allergy? AJR Am J Roentgenol. 2008;190:666–70.CrossRefPubMedGoogle Scholar
  51. Tripathi A, Ditto AM, Grammer LC, Greenberger PA, Mcgrath KG, Zeiss CR, Patterson R. Corticosteroid therapy in an additional 13 cases of Stevens-Johnson syndrome: a Total series of 67 cases. Allergy And Asthma Proceedings. 2000;21:101–5.CrossRefPubMedGoogle Scholar
  52. Viard I, Wehrli P, Bullani R, Schneider P, Holler N, Salomon D, Hunziker T, Saurat JH, Tschopp J, French LE. Inhibition of toxic epidermal necrolysis by blockade of Cd95 with human intravenous immunoglobulin. Science (New York, N.Y.). 1998;282:490–3.CrossRefGoogle Scholar
  53. Young B, Squires K, Patel P, Dejesus E, Bellos N, Berger D, Sutherland-Phillips DH, Liao Q, Shaefer M, Wannamaker P. First large, multicenter, open-label study utilizing Hla-B*5701 screening for Abacavir hypersensitivity in North America. Aids (London, England). 2008;22:1673–5.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Faoud T. Ishmael
    • 1
    • 2
  • Ronaldo Paolo Panganiban
    • 2
  • Simin Zhang
    • 2
  1. 1.Division of Pulmonary and Critical Care Medicine, Section of Allergy and ImmunologyPenn State College of MedicineHersheyUSA
  2. 2.Department of MedicineThe Pennsylvania State University Milton S. Hershey Medical CenterHersheyUSA

Section editors and affiliations

  • Tim Craig
    • 1
  • Massoud Mahmoudi
    • 2
  1. 1.Penn State UniversityHersheyUSA
  2. 2.Department of MedicineUniversity of CaliforniaSan FranciscoUSA

Personalised recommendations